95-25072. Advisory Committees; Filing of Annual Reports  

  • [Federal Register Volume 60, Number 196 (Wednesday, October 11, 1995)]
    [Notices]
    [Page 52918]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-25072]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committees; Filing of Annual Reports
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that, as 
    required by the Federal Advisory Committee Act, the agency has filed 
    with the Library of Congress the annual reports of those FDA advisory 
    committees that held closed meetings during fiscal year 1994. FDA 
    apologizes for the lateness in the filing of these reports due to 
    circumstances beyond the agency's control.
    
    ADDRESSES: Copies are available from the Dockets Management Branch 
    (HFA-305), Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23, 
    Rockville, MD 20857, 301-443-1751.
    
    FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
    Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, -
    Rockville, MD 20857, 301-443-2765.
    
    SUPPLEMENTARY INFORMATION: Under section 13 of the Federal Advisory 
    Committee Act (5 U.S.C. app. 2) and 21 CFR 14.60(c), FDA has filed with 
    the Library of Congress the annual reports for the following FDA 
    advisory committees that held closed meetings during the period October 
    1, 1993, through September 30, 1994:
    Center for Biologics Evaluation and Research: Biological Response 
    Modifiers Advisory Committee, Blood Products Advisory Committee, 
    Vaccines and Related Biological Products Advisory Committee.
    Center for Drug Evaluation and Research: Anesthetic and Life Support 
    Drugs Advisory Committee, Anti-Infective Drugs Advisory Committee, 
    Antiviral Drugs Advisory Committee, Cardiovascular and Renal Drugs 
    Advisory Committee, Dermatologic and Ophthalmic Drugs Advisory 
    Committee (formerly Dermatologic Drugs Advisory Committee), 
    Gastrointestinal Drugs Advisory Committee, -Nonprescription Drugs 
    Advisory Committee, Oncologic Drugs Advisory Committee, -Pulmonary-
    Allergy Drugs Advisory Committee.
    Center for Devices and Radiological Health: Medical Devices Advisory 
    Committee (consisting of reports for the Anesthesiology and Respiratory 
    Therapy Devices Panel; Circulatory System Devices Panel; Clinical 
    Chemistry and Clinical Toxicology Devices Panel (met jointly with the 
    Microbiology Devices Panel); Dental Products Panel; Ear, Nose, and 
    Throat Devices Panel; Gastroenterology and Urology Devices Panel; 
    General and Plastic Surgery Devices Panel; General Hospital and 
    Personal Use Devices Panel; Hematology and Pathology Devices Panel; 
    Immunology Devices Panel; Neurological Devices Panel; Obstetrics and 
    Gynecology Devices Panel; Ophthalmic Devices Panel; Orthopedic and 
    Rehabilitation Devices Panel; and the Radiological Devices Panel).
    Center for Veterinary Medicine: Veterinary Medicine Advisory Committee.
    Office of Science: Science Board to the Food and Drug Administration.
    National Center for Toxicological Research: Science Advisory Board to 
    the National Center for Toxicological Research.
        Annual reports are available for public inspection at: (1) The 
    Library of Congress, Madison Bldg., Newspaper and Current Periodical 
    Reading Room, 101 Independence Ave. SE., rm. 133, Washington, DC; and 
    (2) the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857, 
    between 9 a.m. and 4 p.m., Monday through Friday.
    
        Dated: October 3, 1995.
    David A. Kessler,
    Commissioner of Food and Drugs.
    [FR Doc. 95-25072 Filed 10-10-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Published:
10/11/1995
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
95-25072
Pages:
52918-52918 (1 pages)
PDF File:
95-25072.pdf